Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Vigilant Biosciences
701 Brickell Avenue Suite, 1550
Miami, FL 33131
Phone: 305-728-5382
http://www.vigilantbiosciences.com/

Vigilant Biosciences is a leading innovator and developer of solutions that aid clinicians in the early detection and intervention of cancer. Its point-of-care and lab-based products are accurate, effective and affordable, empowering healthcare practitioners to easily assess the risk of oral cancer early, and improve outcomes through earlier intervention. Vigilant Biosciences' OncAlert Oral Cancer Risk Assessment System™ point-of-care and lab assay products are currently undergoing the CE Mark registration approval process and not yet available for sale in any market at this time.

Key Contact
Name
Matthew H.J. Kim
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
02/25/15 $5,500,000 Series B Institute for Commercialization of Florida Technology
venVelo
White Owl Capital
undisclosed
07/11/16 $5,000,000 Series B-2 venVelo
White Owl Capital
undisclosed